SATFlow – Ultra-Pure Contrast Media Agents

Product Overview

SATFlow is SATMED Health’s premium line of ultra-pure contrast media agents for X-ray, CT, MRI, DSA, and interventional radiology. Every agent is manufactured with advanced high-purity processes that actively remove rare earth element impurities — achieving exceptional cleanliness, minimizing toxicity risk, and delivering clearer, safer contrast-enhanced imaging.

The portfolio spans the full range of modern contrast imaging: macrocyclic gadolinium agents for MRI, iodinated agents for X-ray and CT, ethiodized oil for TACE and vascular embolization, and synthetic triphenylmethane dyes for precise vascular and organ enhancement. CE approval coming soon.

Key Features & Benefits

Rare Earth Removal = Ultra-High Purity

Proprietary manufacturing actively eliminates rare earth element impurities — the trace contaminants other agents retain — reducing long-term toxicity risk and raising the purity bar for patient safety.

Superior X-ray / CT Attenuation

Excellent radiopacity and attenuation for crisp vascular, organ, and tumor visualization across fluoroscopy, CT, and DSA.

Macrocyclic MRI Agents

High-relaxivity macrocyclic gadolinium chelates — the most stable, best-tolerated class of MRI contrast — for detailed soft-tissue contrast.

Ethiodized Oil for TACE & Embolization

Prolonged retention, embolic properties, and outstanding opacification for TACE in hepatocellular carcinoma (HCC), vascular embolization, lymphangiography, and therapeutic vessel occlusion.

Triphenylmethane Dye Agents

Stable, targeted synthetic dyes for selective vascular and organ enhancement where procedural precision is critical.

Low Osmolality & Viscosity

Low-osmolality, low-viscosity profiles improve patient tolerance and reduce the rate of contrast-associated adverse events.

Sterile, Single-Use Packaging

Supports infection control in hybrid OR and interventional suites — every vial guaranteed sterile for every patient.

System Compatibility

Compatible with SATJect injectors, SATLine tubes, and all major contrast delivery systems and imaging platforms.

Our Contrast Media Portfolio — Agents We Supply

Macrocyclic Gadolinium Agents (MRI)

Gadobutrol — high-relaxivity macrocyclic agent delivering exceptional soft-tissue detail and strong T1 shortening at lower doses.
Gadoterate meglumine — ionic macrocyclic agent prized for its kinetic stability and consistent, predictable MRI enhancement.
Gadoteridol — non-ionic macrocyclic agent offering excellent tolerability with the safety advantages of the macrocyclic cage.

Iodinated Contrast Agents (X-ray / CT)

Iohexol — versatile non-ionic monomer trusted worldwide for CT, angiography, and urography.
Iopamidol — non-ionic monomer with a strong safety record across vascular and body CT imaging.
Ioversol — non-ionic monomer engineered for balanced osmolality and smooth injection.
Iopromide — non-ionic monomer optimized for high-quality vascular opacification in angiography and CT.
Iomeprol — non-ionic monomer providing reliable enhancement for routine and interventional CT.
Iobitridol — non-ionic monomer offering low osmolality with high iodine delivery per mL.
Iodixanol — iso-osmolar dimer, the gentler choice for at-risk patients and high-volume injections.
Ioxaglate — ionic dimer combining low osmolality with established clinical utility.

Interventional & Specialty Agents

Ethiodized oil — iodinated oil emulsion for TACE (HCC), vascular embolization, lymphangiography, and therapeutic occlusion; prolonged tumor retention with powerful embolic effect.
Synthetic triphenylmethane dyes — stable, targeted contrast for selective vascular and organ visualization in precision interventional procedures.

Clinical Applications

CT Angiography & Vascular Imaging: High-attenuation iodinated agents for crisp vascular maps.
MRI Enhancement: Macrocyclic gadolinium agents for brain, spine, liver, and soft-tissue imaging.
DSA & Interventional Diagnostics: Reliable contrast for digital subtraction angiography and guided procedures.
TACE (HCC): Ethiodized oil emulsions that lodge in tumor neovasculature with prolonged retention.
Vascular Embolization & Therapeutic Occlusion: Long-lasting radiopacity with controlled embolic effect.
Lymphangiography: Oil-based iodinated formulations for lymphatic vessel imaging.

Technical Specifications

Feature	SATFlow Specification
Product Name	SATFlow – Ultra-Pure Contrast Media Agents (X-ray / CT / MRI / Interventional Series)
Agent Types	Macrocyclic gadolinium (MRI) · Iodinated monomers & dimers (X-ray/CT) · Ethiodized oil · Synthetic triphenylmethane dyes
Purity	Ultra-high — rare earth element impurities actively removed
Indications	CT angiography, MRI enhancement, DSA, TACE (HCC), vascular embolization, lymphangiography, therapeutic occlusion, interventional diagnostics
Packaging	Sterile vials / bottles, various volumes and concentrations
Compatibility	SATJect injectors, SATLine tubes, all major delivery systems
Compliance	CE approval coming soon; additional certifications in process; meets international safety standards for contrast agents

Every SATFlow Order Includes

Sterile single-use agent vials — in the volume and concentration your protocol requires
Ultra-purity guarantee — rare earth removal verified per batch
Full technical documentation — specifications, stability, and handling data
Compatibility assurance — validated with SATJect, SATLine, and major injector systems

Frequently Asked Questions

1. What makes SATFlow contrast agents different from other contrast media brands?

SATFlow agents are manufactured with proprietary processes that actively remove rare earth element impurities, achieving ultra-high purity that standard contrast media do not deliver. Combined with low osmolality, high attenuation, and full modality coverage — from CT and MRI to TACE and vascular embolization — SATFlow offers a cleaner, safer, and more versatile contrast portfolio.

2. What does rare earth removal mean for contrast agent purity and patient safety?

Rare earth elements are trace metallic impurities found in many contrast agents. SATFlow’s advanced manufacturing actively removes them, achieving ultra-high purity that minimizes potential toxicity risks and long-term safety concerns associated with residual contaminants.

3. Which iodinated contrast agents does SATFlow supply?

SATFlow supplies the full range of iodinated CT contrast agents: iohexol, iopamidol, ioversol, iopromide, iomeprol, iobitridol, iodixanol (iso-osmolar dimer), and ioxaglate (ionic dimer) — plus ethiodized oil for interventional procedures.

4. Which macrocyclic gadolinium MRI agents does SATFlow supply?

SATFlow supplies the three leading macrocyclic gadolinium agents: gadobutrol, gadoterate meglumine, and gadoteridol — the most kinetically stable class of MRI contrast agents, preferred for their superior safety profile.

5. What is the difference between macrocyclic and linear gadolinium contrast agents?

Macrocyclic agents (gadobutrol, gadoterate, gadoteridol) cage gadolinium in a rigid molecular ring, making them significantly more stable and far less likely to release free gadolinium ions than linear agents. For this reason, macrocyclic agents are the preferred choice for MRI contrast safety.

6. Is SATFlow ethiodized oil suitable for TACE and vascular embolization?

Yes. SATFlow ethiodized oil is specifically indicated for transarterial chemoembolization (TACE) in hepatocellular carcinoma, vascular embolization, lymphangiography, and therapeutic vessel occlusion — delivering long-lasting radiopacity, prolonged tumor retention, and a powerful embolic effect.

7. Are SATFlow agents compatible with CT, MRI, and DSA equipment?

Yes. SATFlow agents are optimized for X-ray/fluoroscopy, CT, MRI, DSA, and interventional use, and are compatible with SATJect injectors, SATLine tubes, and all major contrast delivery systems and imaging platforms.

8. What is the status of CE approval for SATFlow?

CE approval is coming soon. SATFlow is manufactured to the highest international quality standards and is actively pursuing full CE marking for European markets. Contact us for timeline updates.

9. How much does SATFlow cost, and is it worth it?

SATFlow is competitively priced for hospital volumes — contact us for a quote. The return on investment is strong: improved diagnostic and therapeutic accuracy, fewer repeat procedures, reduced adverse events, and the safety advantage of rare-earth-free ultra purity.

Elevate Visualization & Patient Safety Today

Achieve exceptional, ultra-pure contrast performance across X-ray, CT, MRI, and interventional procedures — including TACE and vascular embolization — with SATFlow. Advanced manufacturing removes rare earth elements for maximum purity. Request a free sample, technical data, or bulk quote now.